Human Phenotype Ontology 
Grandparent Node:
expand
Abnormality of the bladder (HP:0000014)help
Parent Node:
expand
Functional abnormality of the bladder (HP:0000009)help
..Starting node
..expand
Neurogenic bladder (HP:0000011)help
Term ID: 11
Name: Neurogenic bladder
Synonym: Lack of bladder control due to nervous system injury
Definition: A type of bladder dysfunction caused by neurologic damage. Neurogenic bladder can be flaccid or spastic. Common manifestatios of neurogenic bladder are overflow incontinence, frequency, urgency, urge incontinence, and retention.
Comments:
Reference: HP:0000011
Genes and Diseases:
 
       Child Nodes:

 Sister Nodes: 
..expandDetrusor sphincter dyssynergia (HP:0025488) help
..expandDysuria (HP:0100518) help
..expandEnuresis (HP:0000805) help
..expandNocturia (HP:0000017) help
..expandPollakisuria (HP:0100515) help
..expandSpastic/hyperactive bladder (HP:0005340) help
..expandUrinary bladder sphincter dysfunction (HP:0002839) help
..expandUrinary hesitancy (HP:0000019) help
..expandUrinary incontinence (HP:0000020) help
..expandUrinary retention (HP:0000016) help
..expandUrinary urgency (HP:0000012) help
..expandVesicoureteral reflux (HP:0000076) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0000011HP:0000011Neurogenic bladder0ACER3 CL E G H5533116066OMIM:617762Leukodystrophy, progressive, early childhood-onset.
HP:0000011HP:0000011Neurogenic bladder0ARNT2 CL E G H991516876OMIM:615926Webb-Dattani syndrome.
HP:0000011HP:0000011Neurogenic bladder0ATP13A2 CL E G H2340030213ORPHA:513436Autosomal recessive spastic paraplegia type 78HP:0040282 - Frequent100
HP:0000011HP:0000011Neurogenic bladder0ATXN3 CL E G H42877106ORPHA:276238Machado-Joseph disease type 1HP:0040283 - Occasional14
HP:0000011HP:0000011Neurogenic bladder0ATXN3 CL E G H42877106ORPHA:276241Machado-Joseph disease type 2HP:0040283 - Occasional14
HP:0000011HP:0000011Neurogenic bladder0ATXN3 CL E G H42877106ORPHA:276244Machado-Joseph disease type 3HP:0040283 - Occasional14
HP:0000011HP:0000011Neurogenic bladder0CEP85L CL E G H38711921638ORPHA:572013Posterior-predominant lissencephaly-broad flat pons and medulla-midline crossing defects syndrome1
HP:0000011HP:0000011Neurogenic bladder0CHCHD10 CL E G H40091615559OMIM:615911Frontotemporal dementia and/or amyotrophic lateral sclerosis 211
HP:0000011HP:0000011Neurogenic bladder0CHRNA3 CL E G H11361957OMIM:191800URINARY BLADDER, ATONY OF4
HP:0000011HP:0000011Neurogenic bladder0CISD2 CL E G H49385624212OMIM:604928Wolfram syndrome 2.3
HP:0000011HP:0000011Neurogenic bladder0CLCN6 CL E G H11852024OMIM:619173NEURODEGENERATION, CHILDHOOD-ONSET, WITH HYPOTONIA, RESPIRATORY INSUFFICIENCY, AND BRAIN IMAGING ABNORMALITIES; CONRIBA
HP:0000011HP:0000011Neurogenic bladder0COG5 CL E G H1046614857ORPHA:263487COG5-CDGHP:0040283 - Occasional79
HP:0000011HP:0000011Neurogenic bladder0COG5 CL E G H1046614857OMIM:613612CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIi; CDG2I79
HP:0000011HP:0000011Neurogenic bladder0COG7 CL E G H9194918622OMIM:608779Congenital disorder of glycosylation, type IIe.64
HP:0000011HP:0000011Neurogenic bladder0ELOVL1 CL E G H6483414418OMIM:618527Ichthyotic keratoderma, spasticity, hypomyelination, and dysmorphic facial features.
HP:0000011HP:0000011Neurogenic bladder0EN1 CL E G H20193342OMIM:619218ENDOVE SYNDROME, LIMB-BRAIN TYPE; ENDOVESLB1
HP:0000011HP:0000011Neurogenic bladder0EPHB4 CL E G H20503395ORPHA:137667Capillary malformation-arteriovenous malformationHP:0040284 - Very rare3
HP:0000011HP:0000011Neurogenic bladder0ERCC6 CL E G H20743438ORPHA:90324Cockayne syndrome type 3HP:0040282 - Frequent199
HP:0000011HP:0000011Neurogenic bladder0ERCC8 CL E G H11613439ORPHA:90324Cockayne syndrome type 3HP:0040282 - Frequent55
HP:0000011HP:0000011Neurogenic bladder0FARS2 CL E G H1066721062ORPHA:466722Autosomal recessive spastic paraplegia type 77HP:0040283 - Occasional36
HP:0000011HP:0000011Neurogenic bladder0FBXO7 CL E G H2579313586ORPHA:171695Parkinsonian-pyramidal syndromeHP:0040282 - Frequent36
HP:0000011HP:0000011Neurogenic bladder0FUZ CL E G H8019926219ORPHA:1136Arnold-Chiari malformation type IIHP:0040283 - Occasional3
HP:0000011HP:0000011Neurogenic bladder0GBE1 CL E G H26324180ORPHA:206583Adult polyglucosan body diseaseHP:0040281 - Very frequent86
HP:0000011HP:0000011Neurogenic bladder0GBE1 CL E G H26324180OMIM:263570Polyglucosan body neuropathy, adult form86
HP:0000011HP:0000011Neurogenic bladder0GJA1 CL E G H26974274OMIM:164200Oculodentodigital dysplasia68
HP:0000011HP:0000011Neurogenic bladder0GJA1 CL E G H26974274ORPHA:2710Oculodentodigital dysplasiaHP:0040282 - Frequent68
HP:0000011HP:0000011Neurogenic bladder0GNB1 CL E G H27824396OMIM:616973Mental retardation, autosomal dominant 4212
HP:0000011HP:0000011Neurogenic bladder0LIG3 CL E G H39806600OMIM:619780MITOCHONDRIAL DNA DEPLETION SYNDROME 20 (MNGIE TYPE); MTDPS201
HP:0000011HP:0000011Neurogenic bladder0MACF1 CL E G H2349913664ORPHA:572013Posterior-predominant lissencephaly-broad flat pons and medulla-midline crossing defects syndrome2
HP:0000011HP:0000011Neurogenic bladder0MAP3K7 CL E G H68856859OMIM:617137Frontometaphyseal dysplasia 2HP:0040283 - Occasional11
HP:0000011HP:0000011Neurogenic bladder0MARS2 CL E G H9293525133OMIM:611390Spastic ataxia 3, autosomal recessive25
HP:0000011HP:0000011Neurogenic bladder0MNX1 CL E G H31104979OMIM:176450Currarino syndrome.17
HP:0000011HP:0000011Neurogenic bladder0MTFMT CL E G H12326329666OMIM:618248Mitochondrial complex I deficiency, nuclear type 27.29
HP:0000011HP:0000011Neurogenic bladder0PEX3 CL E G H85048858OMIM:617370Peroxisome biogenesis disorder 10B.47
HP:0000011HP:0000011Neurogenic bladder0PLP1 CL E G H53549086ORPHA:280229Pelizaeus-Merzbacher disease in female carriersHP:0040283 - Occasional60
HP:0000011HP:0000011Neurogenic bladder0PPOX CL E G H54989280ORPHA:79473Porphyria variegataHP:0040283 - Occasional41
HP:0000011HP:0000011Neurogenic bladder0RASA1 CL E G H59219871ORPHA:137667Capillary malformation-arteriovenous malformationHP:0040284 - Very rare88
HP:0000011HP:0000011Neurogenic bladder0SNCA CL E G H662211138ORPHA:171695Parkinsonian-pyramidal syndromeHP:0040282 - Frequent65
HP:0000011HP:0000011Neurogenic bladder0TBCD CL E G H690411581ORPHA:496641Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndromeHP:0040284 - Very rare16
HP:0000011HP:0000011Neurogenic bladder0TBCK CL E G H9362728261ORPHA:488632TBCK-related intellectual disability syndromeHP:0040284 - Very rare13
HP:0000011HP:0000011Neurogenic bladder0TRAPPC12 CL E G H5111224284ORPHA:500144Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndromeHP:0040283 - Occasional2
HP:0000011HP:0000011Neurogenic bladder0VANGL1 CL E G H8183915512OMIM:600145Sacral defect with anterior meningocele.111
HP:0000011HP:0000011Neurogenic bladder0VPS11 CL E G H5582314583OMIM:616683Leukodystrophy, hypomyelinating, 121
HP:0000011HP:0000011Neurogenic bladder0VPS11 CL E G H5582314583ORPHA:466934VPS11-related autosomal recessive hypomyelinating leukodystrophyHP:0040282 - Frequent1
HP:0000011HP:0000011Neurogenic bladder0WFS1 CL E G H746612762OMIM:222300Wolfram syndrome 1.389


Genes (39) :ACER3 ARNT2 ATP13A2 ATXN3 CEP85L CHCHD10 CHRNA3 CISD2 CLCN6 COG5 COG7 ELOVL1 EN1 EPHB4 ERCC6 ERCC8 FARS2 FBXO7 FUZ GBE1 GJA1 GNB1 LIG3 MACF1 MAP3K7 MARS2 MNX1 MTFMT PEX3 PLP1 PPOX RASA1 SNCA TBCD TBCK TRAPPC12 VANGL1 VPS11 WFS1

Diseases (41) :OMIM:617762 OMIM:615926 ORPHA:513436 ORPHA:276238 ORPHA:276241 ORPHA:276244 ORPHA:572013 OMIM:615911 OMIM:191800 OMIM:604928 OMIM:619173 ORPHA:263487 OMIM:613612 OMIM:608779 OMIM:618527 OMIM:619218 ORPHA:137667 ORPHA:90324 ORPHA:466722 ORPHA:171695 ORPHA:1136 ORPHA:206583 OMIM:263570 OMIM:164200 ORPHA:2710 OMIM:616973 OMIM:619780 OMIM:617137 OMIM:611390 OMIM:176450 OMIM:618248 OMIM:617370 ORPHA:280229 ORPHA:79473 ORPHA:496641 ORPHA:488632 ORPHA:500144 OMIM:600145 OMIM:616683 ORPHA:466934 OMIM:222300
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.